Announcements Trials
Browse Landscape

Phase

Phase NA 9Phase 4 1

Status

Terminated 1Enrolling by invitation 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 8Prostatic Neoplasms 6Papillomavirus Infections 6Neoplasms 6Polycystic Ovary Syndrome 3Colorectal Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Tuberous Sclerosis 2Thyroid Neoplasms 2Stomach Neoplasms 2Smoking Cessation 2Sarcoma 2Rectal Neoplasms 2Pancreatic Neoplasms 2Multiple Myeloma 2Leukemia, Myeloid, Acute 2Hematologic Neoplasms 2Head and Neck Neoplasms 2Graft vs Host Disease 2Dupuytren Contracture 2Diabetes Mellitus 2Dementia 2Cardiovascular Diseases 2Carcinoma, Hepatocellular 2Wrist Fractures 1Vaccine-Preventable Diseases 1Uterine Cervical Neoplasms 1Tobacco Use Cessation 1Thyroid Diseases 1Thalassemia 1

Interventions

enzalutamide 1Prednisone 1Gonadotropin-Releasing Hormone 1Abiraterone Acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Active not recruiting × Cognitive Dysfunction × Clear all
NCT03016741 2026-02-24

Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate Cancer

Northwestern University

Phase 4 Active not recruiting
100 enrolled
Genitourinary

Dementia, Prostatic Neoplasms, Cognitive Dysfunction, Prostatic Neoplasms, Castration-Resistant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡